Financials
- Market Capitalization 595.01 M
- Employee 246
- Founded 2013
- CEO N/A
- Website www.arvinas.com
- Headquarter Delaware, United States
- FIGI BBG00LW7YK82
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
34.62
Relación precio/flujo de caja
1.75
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2802 | ALT Altimmune, Inc. - Common Stock | 3.10 USD | -0.32% | -0.32% | +7.64% | -18.64% | 603.00 M USD | ||
| 2810 | SPRY ARS Pharmaceuticals, Inc. - Common Stock | 5.98 USD | +1.53% | +10.95% | +17.72% | -35.07% | 594.70 M USD | ||
| 2829 | MPLT MapLight Therapeutics, Inc. - Common Stock | 12.42 USD | -1.43% | +10.11% | -3.35% | -34.63% | 576.01 M USD | ||
| 2844 | CAPR Capricor Therapeutics, Inc. - Common Stock | 9.91 USD | +3.34% | +43.62% | +162.17% | +58.31% | 576.16 M USD |